Finjan Holdings Inc (NASDAQ:FNJN) shares saw an uptick in trading volume on Tuesday . 32,387 shares changed hands during trading, a decline of 93% from the previous session’s volume of 494,407 shares.The stock last traded at $4.98 and had previously closed at $5.08.
A number of brokerages have weighed in on FNJN. ValuEngine cut shares of Finjan from a “buy” rating to a “hold” rating in a report on Thursday, August 2nd. TheStreet raised shares of Finjan from a “c+” rating to a “b-” rating in a report on Tuesday, August 14th.
Get Finjan alerts:The firm has a market capitalization of $117.42 million, a price-to-earnings ratio of 13.88 and a beta of -0.69.
Finjan (NASDAQ:FNJN) last issued its earnings results on Thursday, August 2nd. The software maker reported $0.24 earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.06) by $0.30. The business had revenue of $17.30 million for the quarter, compared to analyst estimates of $7.50 million. Analysts forecast that Finjan Holdings Inc will post 1.49 EPS for the current fiscal year.
Top 10 Undervalued Stocks To Own For 2021: Apple Hospitality REIT, Inc.(APLE)
The Company, formed in November 2007 as a Virginia corporation, is a self-advised real estate investment trust ("REIT") that invests in income-producing real estate, primarily in the lodging sector, in the United States. As of December 31, 2015, the Company owned 179 hotels operating in 32 states with an aggregate of 22,961 rooms. All of the Company's hotels operate under Marriott or Hilton brands. The Company has elected to be treated as a REIT for federal income tax purposes. The Company has wholly-owned taxable REIT subsidiaries, which lease all of the Company's hotels from wholly-owned qualified REIT subsidiaries. The hotels are operated and managed under separate management agreements with 20 hotel management companies, none of which are affiliated with the Company. On May 18, 2015, the Company's common shares were listed and began trading on the New York Stock Exchange ("NYSE") under the ticker symbol "APLE" (the "Listing"). Advisors' Opinion:
- [By Logan Wallace]
New York REIT (NYSE:NYRT) and Apple Hospitality REIT (NYSE:APLE) are both finance companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, dividends, institutional ownership, analyst recommendations, earnings and valuation.
- [By Motley Fool Transcribers]
Apple Hospitality REIT Inc (NYSE:APLE)Q4 2018 Earnings Conference CallFeb. 26, 2019, 9:00 a.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
Top 10 Undervalued Stocks To Own For 2021: Ebix, Inc.(EBIX)
Ebix, Inc. (Ebix), incorporated on December 29, 2003, is a supplier of software and e-commerce solutions to the insurance, finance and healthcare industries. The Company provides application software products for the insurance industry, including carrier systems, agency systems and exchanges, as well as custom software development. The Company conducts its operations through four channels, which include Exchanges, Carrier Systems, Broker Systems and Risk Compliance Solutions (RCS). Ebix operates data exchanges in the areas of life insurance, annuities, employee health benefits, risk management, workers compensation, and property and casualty (P&C) insurance. Ebix's focus in the area of broker systems is on designing and deploying back-end systems for international P&C insurance brokers across the world. Ebix's focus in the area of carrier systems is on designing and deploying on-demand and back-end systems for P&C insurance companies. Ebix focus in RCS channel pertains to business process outsourcing services that include providing domain intensive project management, time and material consulting to clients across the world, and claims adjudication/settlement services, in addition to the creation and tracking of certificates of insurance issued in the United States and Australian markets. Ebix also provides software development, customization and consulting services to various entities in the insurance industry, including carriers, brokers, exchanges and standard making bodies.
Exchanges
The Company's data exchanges connect various entities within the insurance markets enabling the participant to carry and process data from one end to another. Its life, annuity and employee health benefit exchanges operate primarily in the United States, while the P&C exchanges operates primarily in Australia, New Zealand, the United Kingdom and Brazil. Ebix operates a processing end-to-end Life Exchange service that has over three life insurance exchanges in the United States, such as Winfle! x, TPP and LifeSpeed. Winflex is an exchange for pre-sale life insurance illustrations between brokers and carriers; TPP is an underwriting and customized electronic application platform for Life insurance, and LifeSpeed is an order entry platform for life insurance. Ebix operates a processing end-to-end Annuity Exchange service that has over three life insurance exchanges in the United States, such as Annuitynet, AMP and AN4. The Company's exchanges are platforms for annuity transactions between brokers, carriers, broker general agents (BGA's) and other entities involved in annuity transactions. Ebix's customer relationship management (CRM) exchange, SmartOffice, is designed for insurance companies, general agents, banks, financial advisors and investment dealers. Smart Office is integrated into EbixExchange Life, Health, P&C and Annuity exchanges.
The Company provides employee benefit and health insurance exchange services using over four platforms, such as Facts, LumininX, HealthConnect and EbixEnterprise. Ebix's platforms are sold to health carriers and third party administrators. The platforms provide a range of services, such as employee enrollment, claims adjudication, accounting, employee benefits administration accounting and compliance. The HealthConnect insurance quoting portals service the individual and small group marketplace. Through A.D.A.M. Health Solutions, Ebix provides multimedia health content, training, patient education and continuing education for various Websites, doctors, consumer health portals, country governments, hospitals, healthcare, biomedical, medical device, pharmaceutical and education organizations. Ebix operates P&C exchanges in Australia, New Zealand, the United Kingdom and the United States.
The Company competes with iPipeline, Salesforce.com, Redtail, Trizetto, BenefitFocus, Ultimate Software, Krames Staywell, Red Nucleus and Anatomy One.
Broker P&C Systems
The Company offers a number of broker system offerings ! for P&C b! rokers across the world, which include eGlobal, which targets multinational P&C insurance brokers; WinBeat, which targets P&C brokers in the Australian and New Zealand markets, and EbixASP, which is a system for the P&C insurance brokers in the United States. eGlobal is multilingual and multicurrency, and is available in various languages, such as English, Chinese, Japanese, French, Portuguese and Spanish. EbixASP is designed around the Association for Cooperative Operations Research and Development (ACORD) insurance standards used in the United States. The Company's main focus in the broker systems channel is on markets outside the United States.
The Company competes with Lumley, SSP, Vertafore, Applied Systems and XDimensional.
Risk Compliance Solutions
The Company's RCS channel focuses on helping its clients outsource any specific service or manpower to the Company on an onsite or offshore basis. Ebix's RCS certificate outsourcing business services are enabled by the Company's software as a service (SaaS)-based software. Ebix's RCS service offerings cater to a number of companies in the United States. Ebix provides a software-based service for issuance of certificates of insurance that adheres to industry standards, such as ACORD.
The Company competes with Applied Systems, Datamonitor, CMS and Exigis.
Carrier P&C Systems
The Company has various carrier system offerings for P&C carriers, such as Ebix Advantage and Ebix AdvantageWeb. Ebix Advantage is targeted at P&C carriers in the United States that operate in the personal, commercial and specialty line areas of insurance. Ebix AdvantageWeb is designed for the international markets, and is targeted at the small, medium and large P&C carriers in the international markets that operate in the personal, commercial and specialty line areas of insurance. Ebix AdvantageWeb is designed to be multicurrency and multilingual, and is deployed in Brazil, the United Kingdom and the Unite! d States.!
The Company competes with CSC, Guidewire, Xchanging, Accenture and Delphi.
Advisors' Opinion:- [By Logan Wallace]
COPYRIGHT VIOLATION WARNING: “Ebix Inc (EBIX) Holdings Cut by Royce & Associates LP” was posted by Ticker Report and is owned by of Ticker Report. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright & trademark legislation. The correct version of this report can be read at https://www.tickerreport.com/banking-finance/4220018/ebix-inc-ebix-holdings-cut-by-royce-associates-lp.html.
- [By Rich Smith]
Shares of Indian travel website Yatra Online (NASDAQ:YTRA) surged roughly 31% Monday after on-demand software company Ebix (NASDAQ:EBIX) -- which earlier this month reported strong sales growth but drastically reduced profits -- launched an effort to diversify its business by making an offer to buy Yatra.
Top 10 Undervalued Stocks To Own For 2021: Guaranty Bancorp(GBNK)
Guaranty Bancorp (the "Company") is a bank holding company registered under the Bank Holding Company Act of 1956, as amended (the "BHC Act") and headquartered in Colorado. The Company's principal business is to serve as a holding company for our bank subsidiary, Guaranty Bank and Trust Company referred to as "Guaranty Bank" or "Bank". References to the "Company", "us", "we" and "our" refer to Guaranty Bancorp on a consolidated basis. References to "Guaranty Bancorp" or to the "holding company" refer to the parent company on a stand-alone basis. At December 31, 2015, we had total assets of $2.4 billion, net loans of $1.8 billion, deposits of $1.8 billion and stockholders' equity of $221.6 million, and we operated 26 branches and two investment management firms in Colorado through our bank subsidiary, Guaranty Bank. Advisors' Opinion:
- [By Ethan Ryder]
Get a free copy of the Zacks research report on Guaranty Bancorp (GBNK)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Shane Hupp]
Guaranty Bancorp (NASDAQ:GBNK) and County Bancorp (NASDAQ:ICBK) are both small-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, analyst recommendations, dividends, risk and institutional ownership.
- [By Ethan Ryder]
Guaranty Bancorp (NASDAQ:GBNK) has earned a consensus recommendation of “Hold” from the six brokerages that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $34.63.
Top 10 Undervalued Stocks To Own For 2021: Renewable Energy Group, Inc.(REGI)
We intend to become a leading producer of advanced biofuels and renewable chemicals. We are currently the largest producer of biodiesel in the United States based on gallons produced. We participate in each aspect of biodiesel production, from acquiring feedstock, managing construction and operating biodiesel production facilities to marketing, selling and distributing biodiesel and its co-products. During 2013, we sold 259 million gallons of biodiesel and had total revenues of $1.5 billion. Advisors' Opinion:
- [By Alex Sirois]
The company’s two primary markets include behind-the-meter solar storage and grid connected storage, making up 99% of its $2.9 billion portfolio.
Clean Energy Stocks for ‘Code Red’: Renewable Energy Group (REGI) Source: ShutterstockIt’s probably best to start with analyst expectations around price when discussing Renewable Energy Group right now. REGI stock is arguably in a buy-the-dip situation currently.
- [By Motley Fool Transcribing]
Renewable Energy Group (NASDAQ:REGI) Q4 2018 Earnings Conference CallMarch 5, 2019 4:30 p.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
Top 10 Undervalued Stocks To Own For 2021: Starwood Hotels & Resorts Worldwide, Inc.(HOT)
Starwood Hotels & Resorts Worldwide, Inc., incorporated on March 27, 1980, is a hotel and leisure company. The Company's hotel business is focused on the global operation of hotels and resorts primarily in the luxury and upper upscale segments of the lodging industry. The Company manages and operates its hotel business in three hotel segments: the Americas; Europe, Africa and the Middle East (EAME), and Asia Pacific. Its vacation ownership and residential business is a separate segment. The Company conducts its hotel and leisure business both directly and through its subsidiaries. The Company owns Starwood Vacation Ownership, Inc., a provider of vacation experiences through villa-style resorts and access to Starwood brands. The Starwood Preferred Guest (SPG) program is the Company's traveler, customer loyalty and multi-brand marketing program. This program allows members to earn and redeem points for room stays, room upgrades and airline flights, with no blackout dates. The SPG program is rewarding loyalty program in the hospitality industry. The Company also develops, owns and operates vacation ownership resorts, markets and sells the vacation ownership Interests (VOIs) in the resorts and, in many cases, provides financing to customers who purchase such ownership interests.
The Company has approximately 1,297 properties providing over 370,000 rooms in approximately 100 countries. The Company's hotel business include approximately 1,282 owned, managed or franchised hotels with over 362,300 rooms, comprising 30 hotels that it owns or leases or in which the Company has a majority equity interest, over 610 hotels managed by the Company on behalf of third-party owners and approximately 640 hotels for which it receives franchise fees. The Company's approximately 30 hotels include The St. Regis, San Francisco; The St. Regis, New York; W New York-Times Square; The Westin Peachtree Plaza, Atlanta; The Westin Maui Resort & Spa, Ka'anapali; Sheraton Kauai Resort; Sheraton Steamboat Resort; The Trem! ont Chicago Hotel at Magnificent Mile; Park Tower, Buenos Aires; Hotel Goldener Hirsch, Salzburg; The Westin Resort & Spa, Puerto Vallarta; The Westin Resort & Spa, Los Cabos; Sheraton Buenos Aires Hotel & Convention Center; Sheraton Gateway Hotel in Toronto International Airport, and Sheraton Paris Airport Hotel & Conference Centre, among others. In addition, the Company's vacation ownership and residential business includes approximately 15 stand-alone vacation ownership resorts and residential properties.
The Company's brands include St. Regis, The Luxury Collection, W, Westin, Le Meridien, Sheraton, Four Points, Aloft, Element and Tribute Portfolio. All brands (other than the Four Points by Sheraton, the Aloft and Element brands) represent full-service properties that range in amenities from luxury hotels to priced hotels. Its Four Points by Sheraton, Aloft and Element brands are select-service properties that cater to consumers.
Advisors' Opinion:- [By Joseph Griffin]
Hydro Protocol (CURRENCY:HOT) traded 3.1% higher against the US dollar during the 24 hour period ending at 22:00 PM Eastern on March 12th. Over the last week, Hydro Protocol has traded up 14.6% against the US dollar. Hydro Protocol has a market cap of $2.22 million and approximately $29,910.00 worth of Hydro Protocol was traded on exchanges in the last 24 hours. One Hydro Protocol token can currently be bought for $0.0032 or 0.00000081 BTC on cryptocurrency exchanges including OKEx, DDEX, Bancor Network and Bgogo.
- [By Stephan Byrd]
Hydro Protocol (CURRENCY:HOT) traded 0.2% higher against the U.S. dollar during the one day period ending at 0:00 AM ET on October 5th. Over the last seven days, Hydro Protocol has traded 2.8% lower against the U.S. dollar. Hydro Protocol has a total market cap of $7.33 million and $54,859.00 worth of Hydro Protocol was traded on exchanges in the last 24 hours. One Hydro Protocol token can now be purchased for approximately $0.0104 or 0.00000158 BTC on major exchanges including DDEX, Bancor Network, HADAX and Ethfinex.
- [By Shane Hupp]
Holo (CURRENCY:HOT) traded 0.8% lower against the US dollar during the 24 hour period ending at 20:00 PM E.T. on September 22nd. Holo has a market cap of $148.52 million and approximately $5.90 million worth of Holo was traded on exchanges in the last 24 hours. One Holo token can currently be purchased for approximately $0.0011 or 0.00000017 BTC on major exchanges including IDEX, LATOKEN, Binance and Hotbit. In the last seven days, Holo has traded up 0.1% against the US dollar.
- [By Logan Wallace]
Holo (CURRENCY:HOT) traded 1.6% lower against the US dollar during the one day period ending at 18:00 PM ET on August 18th. Holo has a market capitalization of $82.13 million and approximately $2.55 million worth of Holo was traded on exchanges in the last 24 hours. One Holo token can currently be bought for $0.0006 or 0.00000010 BTC on cryptocurrency exchanges including Hotbit, Binance, Fatbtc and Radar Relay. Over the last seven days, Holo has traded 5.3% lower against the US dollar.
Top 10 Undervalued Stocks To Own For 2021: Zogenix, Inc.(ZGNX)
We are a pharmaceutical company committed to developing and commercializing central nervous system, or CNS, therapies that address specific clinical needs for people living with orphan and other CNS disorders who need innovative treatment alternatives to help them improve their daily functioning. Our current areas of focus are epilepsy and schizophrenia. Our lead product candidate is ZX008, a low-dose fenfluramine for the treatment of seizures associated with Dravet syndrome. Dravet syndrome is a rare and catastrophic form of pediatric epilepsy with life threatening consequences for patients and for which current treatment options are very limited. ZX008 has received orphan drug designation in the United States and Europe for the treatment of Dravet syndrome. In January 2016, we received notification of Fast Track designation from the U.S. Food and Drug Administration, or FDA, for ZX008 for the treatment of Dravet syndrome. Advisors' Opinion:
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Zogenix (ZGNX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Todd Campbell]
After Zogenix (NASDAQ:ZGNX) announced it has submitted marketing applications in the U.S. and Europe for approval for Fintepla (formerly ZX008) for treatment of Dravet syndrome, shares gained 20.5% in February, according to S&P Global Market Intelligence.
Top 10 Undervalued Stocks To Own For 2021: Seres Therapeutics, Inc.(MCRB)
Seres Therapeutics, Inc., a microbiome therapeutics platform company, focuses on the development of biological drugs designed to restore health by repairing the function of a dysbiotic microbiome. Its lead product candidate is SER-109, a bacterial spore ecology, which has completed open label Phase Ib/2 clinical study for the prevention of further recurrences of Clostridium difficile infection (CDI). The company also develops SER-287 that is in phase Ib clinical study to treat inflammatory bowel disease, including ulcerative colitis. Its product candidates in pre-clinical development comprise SER-262, an Ecobiotic microbiome therapeutic designed to be used following antibiotic treatment of primary CDI; and SER-155 for the prevention of transplant-related mortality. Seres Therapeutics, Inc. has a strategic collaboration with Nestle Health Science. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Shares of Seres Therapeutics (NASDAQ:MCRB), a biopharmaceutical company focused on the microbiome, jumped 64% after partnering with AstraZeneca (NYSE:AZN) to test a unique cancer therapy candidate in combination with Imfinzi. Excited investors pushed the stock 64.2% higher in early morning trading, but the stock's gain settled to 28.8% as of 1:04 p.m. EDT on Monday. Seres Therapeutics Inc (NASDAQ:MCRB)Q4 2018 Earnings Conference CallMarch 06, 2019, 8:30 a.m. ET Operator Seres Therapeutics (NASDAQ:MCRB) was upgraded by investment analysts at ValuEngine from a “sell” rating to a “hold” rating in a research report issued on Tuesday. Seres Therapeutics Inc (NASDAQ:MCRB) CEO Roger Pomerantz sold 26,492 shares of the firm’s stock in a transaction dated Wednesday, June 20th. The shares were sold at an average price of $9.33, for a total value of $247,170.36. Following the transaction, the chief executive officer now owns 297,812 shares of the company’s stock, valued at $2,778,585.96. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. MFS Municipal Income Trust (the Trust) is a non-diversified, closed-end management investment company. The fund's objective is to seek high current income. MFS Municipal Income Trust invests at least 80% of its net assets in municipal bonds (debt securities issued by or on behalf of states, territories, possessions of the United States, District of Columbia and their political subdivisions, agencies or instrumentalities). The Fund's investment portfolio includes healthcare, industrials, tobacco, transportation and utilities. MFS Municipal Income Trust's investment advisor is Massachusetts Financial Services Company. News headlines about MFS Municipal Income Trust (NYSE:MFM) have been trending somewhat positive on Sunday, Accern Sentiment Analysis reports. The research group identifies negative and positive news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. MFS Municipal Income Trust earned a media sentiment score of 0.02 on Accern’s scale. Accern also gave news articles about the closed-end fund an impact score of 46.4351075510345 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days. Doliver Capital Advisors LP lessened its stake in MFS Municipal Income Trust (NYSE:MFM) by 51.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 19,505 shares of the closed-end fund’s stock after selling 20,769 shares during the period. Doliver Capital Advisors LP’s holdings in MFS Municipal Income Trust were worth $127,000 as of its most recent SEC filing. Sandridge Permian Trust (the Trust), incorporated on May 12, 2011, is a statutory trust. The Trust holds Royalty Interests in specified oil and natural gas properties in the Permian Basin located in Andrews County, Texas (the Underlying Properties). The Trust's business activities are generally limited to owning the Royalty Interests, and entering into hedging arrangements at the inception of the Trust and activities related thereto, including activities required or permitted by the terms of the conveyances related to the Royalty Interests. The Trust's properties consist of Royalty Interests in the initial wells and over 860 additional wells (equivalent to over 890 trust development wells under the development agreement) that are drilled and perforated for completion. The Royalty Interests are in properties located in the greater Fuhrman-Mascho field, a field in Andrews County, Texas that produces oil primarily from the Grayburg/San Andres formation in the Permian Basin. The Permian Basin extends throughout southwestern Texas and southeastern New Mexico over an area approximately 250 miles wide and over 300 miles long. The Royalty Interests entitle the Trust to receive over 80% of the proceeds from the sale of oil, natural gas and natural gas liquids (NGLs) production attributable to SandRidge Energy, Inc. (SandRidge)'s net revenue interest in over 520 oil and natural gas wells developed, including over 20 wells awaiting completion at the time and over 70% of the proceeds from the sale of oil, natural gas and NGL production attributable to SandRidge's net revenue interest in over 890 development wells drilled within an area of mutual interest (AMI). SandRidge sells oil, natural gas and NGL from the Underlying Properties to a range of customers, including oil and natural gas companies, and trading and energy marketing companies. Media coverage about SandRidge Permian Trust (NYSE:PER) has been trending somewhat positive this week, according to Accern. Accern rates the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. SandRidge Permian Trust earned a coverage optimism score of 0.04 on Accern’s scale. Accern also gave news headlines about the oil and gas producer an impact score of 46.3601951962152 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future. NeoGenomics, Inc., through its subsidiaries, operates a network of cancer-focused genetic testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry and digital imaging testing services to localize proteins in cells of a tissue section, as well as to allow clients to see and utilize scanned slides, and perform quantitative analysis for certain stains; and molecular testing services that focus on the analysis of DNA and RNA, and the structure and function of genes at the molecular level. The company also provides pathology consultation services for clients in which its pathologists review surgical samples on a consultative basis; and testing services in support of its pharmaceutical clients' oncology programs, as well as acts as a reference laboratory supplying anatomic pathology testing services. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida. We're talking about stocks like pharmacy automation firm Omnicell (OMCL), nurse and doctor staffing software operator AMN Healthcare Services (AMN) and cancer testing services provider NeoGenomics (NEO) to name a few. February was a great month for genetic testing stocks. Shares of Invitae (NYSE:NVTA) paced the pack with a monthly gain of 42.9%, according to data provided by S&P Global Market Intelligence. That was followed by NeoGenomics (NASDAQ:NEO) and Myriad Genetics (NASDAQ:MYGN), which rose 17.9% and 10.1%, respectively.Top 10 Undervalued Stocks To Own For 2021: MFS Municipal Income Trust(MFM)
Top 10 Undervalued Stocks To Own For 2021: SandRidge Permian Trust(PER)
Top 10 Undervalued Stocks To Own For 2021: NeoGenomics, Inc.(NEO)
No comments:
Post a Comment